z-logo
open-access-imgOpen Access
Immunoglobulin G4 ‐related disease: a rare steroid‐responsive disease
Author(s) -
Thanthitaweewat Vorawut,
Chantranuwatana Poonchavist,
Chirakalwasan Naricha
Publication year - 2017
Publication title -
respirology case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.304
H-Index - 9
ISSN - 2051-3380
DOI - 10.1002/rcr2.231
Subject(s) - medicine , prednisolone , pathology , bronchoalveolar lavage , igg4 related disease , malignancy , serum protein electrophoresis , mediastinal lymphadenopathy , infiltration (hvac) , antibody , gastroenterology , biopsy , disease , lung , immunology , monoclonal , monoclonal antibody , physics , thermodynamics
A 70‐year‐old man presented with progressive dyspnoea and weight loss. Physical examination revealed only mild pale conjunctiva. The workup showed mild anaemia, mild impaired renal function, and high globulin level. Multiple myeloma was excluded by normal serum protein electrophoresis. The chest radiography and computed tomography (CT) revealed bilateral multifocal patchy infiltration with mediastinal adenopathy. Bronchoscopy was performed. Bronchoalveolar lavage ( BAL ) fluid examination was negative for infection and malignancy. Tissue pathology revealed diffuse lymphoplasmacytic cell infiltration. Immunohistochemistry revealed positive highlight for CD38 , immunoglobulin G ( IgG ), and IgG4 . Serum IgG subclass was requested and showed an IgG4 level of 7230 mg/dL. Examination of bone marrow and submental lymph node pathology were also positive for IgG4 . IgG4 ‐related disease with pulmonary involvement was diagnosed. Treatment with prednisolone (30 mg/day) resulted in improvement in his dyspnoea and almost complete resolution of the pulmonary infiltration on repeated CT at 6 month. This case highlighted a rare occurrence of IgG4 ‐related disease which was successfully treated with steroid.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here